Feb 7 |
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
|
Feb 7 |
Enanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ...
|
Feb 7 |
Enanta Pharma GAAP EPS of -$1.58 misses by $0.35, revenue of $18M misses by $3.95M
|
Feb 7 |
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
|
Feb 7 |
Earnings Scheduled For February 7, 2024
|
Feb 6 |
Enanta Pharma Q1 2024 Earnings Preview
|
Feb 6 |
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Jan 31 |
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
|
Jan 5 |
Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
|
Jan 4 |
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
|